Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Her Excellency Marie Bashir Sees Bridges to Peace at Hadassah's Hospitals

"You are in the best place in the world, where everyone cares for your son," Her Excellency, Professor and Governor of New South Wales Marie Bashir said. She was speaking to the mother of Baby Ali—in Arabic—during her recent visit to the Hadassah Medical Organization. The mother responded, “I know.”

Ali was born with a life-threatening immune deficiency that affects his lungs. He is being cared for under the direction of Dr. Phillip Toltzis, head of Hadassah's Pediatric Intensive Care Unit, which Hadassah Australia has supported.

Dr. Bashir, a medical doctor and a psychiatrist, spent two mornings visiting Hadassah Hospital in Ein Kerem and in Mount Scopus. During her visit to Mt. Scopus, she visited the newly dedicated Jack and Robert Smorgon Families Foundation Healing and Environmental Garden, a project of Hadassah Australia, in partnership with Kerem Kayemet L'Yisroel (KKL)/Jewish National Fund (JNF) Australia.

While touring the pediatric hemato-oncology unit with Unit Head Dr. Michael Weintraub, Dr. Bashir met young patients from Israel and the West Bank who are undergoing treatment for cancer and genetic diseases. 10-year-old Nuraladin, from the West Bank city of Nablus, was surprised, his mother said, when the elegant lady from Australia addressed him in Arabic.

A further highlight of the Governor’s visit was meeting with Dr. Amal Bishara, who heads Hadassah's bone marrow registry for Arabs.

Although only about 1.2 million of the world’s 400 million ethnic Arabs live in Israel, the sole registry for Arab bone marrow donors is located in Jerusalem. To date, Israel’s Arab registry has found successful bone marrow matches for 36 patients. Requests for donors continue to flow in from around the globe.

"The whole world should see what is going on at Hadassah Hospital," said Dr. Bashir. "Here we all know we're part of the same human family.”


Date: 7/8/2014

Hadassah Stem Cell Expert Speaks at TEDx Conference in Jaffa

FDA Grants Approval for US Clinical Trials of Hadassah-Developed Technology to Treat Fatty Liver Disease

Hadassah Physicians Receive Prestigious Grants and Awards

New Research at Hadassah: Computational Tools Unravel the Mystery of Transient Amnesia

From Life-Threatening Brain Bleed to Birth of a Daughter

Cookbook Author, Rabbi Marks, Spends Last Days at Hadassah's Hospice

Hadassah’s Revolutionary Tipat Halav Clinics of 1920s Featured in Jerusalem Old City Museum

Victims of Terror Share Their Stories of Anguish and Appreciation with Hadassah President

Hadassah’s Advanced Gene Sequencing Changes the Life of a Family from Uzbekistan

IDF Medic Heroically Battles Terrorist, Both Treated at Hadassah

Orthopedic Trauma Turns Tragedy into Innovation at Hadassah

On the Cutting-Edge of Melanoma Treatment: Hadassah’s Protocols and Research

Saving a Newborn from a Life Without Sight

Terrorist and Victim Sent to Hadassah's Hospitals After Third Attack in Two Weeks

Three Sent to Hadassah After Second Jerusalem Terror Attack of the Week

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

“We Don’t Say ‘No’,” Hadassah Neurosurgeon Explains in Operating on 82-Year-Old Patient

Cutting-Edge Medicine and Research; a Role Model for Peace: A Briefing from the Hospital's Director General

4 Ways Hadassah Hospital is Preparing for Ebola—Just in Case

Hailing from 17 Countries: the 39th Graduation Class of Hadassah’s International Master of Public Health Program



More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America